Brief: Natco Pharma Dec-Quarter Consol Net Profit Rises
14/02/2024 09:00
Feb 14 (Reuters) - Natco Pharma Ltd NATP.NS :
* NATCO PHARMA LTD DEC-QUARTER CONSOL NET PROFIT 2.13
BILLION
RUPEES VERSUS 623 MILLION RUPEES
* NATCO PHARMA LTD DEC-QUARTER CONSOL REVENUE FROM
OPERATIONS 7.59
BILLION RUPEES VERSUS 4.93 BILLION RUPEES
Source text for Eikon: ID:
Further company coverage: NATP.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Natco Pharma
See all newsBrief: Natco Pharma Launches Carboplatin Injection In Us With Teyro Labs
India's Natco Pharma jumps after launching ovarian cancer drug in US
Brief: Natco Pharma Announces Launch Of Carboplatin Injection In The U.S. Market
Brief: Natco Pharma To Increase Its Investment In Egenesis To $16.70 Million
Brief: Natco Pharma Approves Rights Issue Up To 12.79 Billion Rupees